Treatment of high-risk follicular lymphoma by Wojciech Jurczak

Get full text

Biosimilars for Haematologic Malignancies: The Path to Sustainable Care by Paul Cornes, Arnold G. Vulto, Wojciech Jurczak

Get full text

Corrosion and Cavitation Resistances of Low Alloy Steel after Frictional-Mechanical Treatment by Dorota Kocańda, Wojciech Jurczak, Ellina Łunarska, Michał Szociński

Get full text

Testing of Technical Fabrics under Fast Camera Control by Paweł Kłosowski, Krystyna Michałowska, Marek Przyborski, Wojciech Jurczak

Get full text

Static and Dynamic Properties of Al-Mg Alloys Subjected to Hydrostatic Extrusion by Wojciech Jurczak, Tomasz Trzepieciński, Andrzej Kubit, Wojciech Bochnowski

Get full text

Surface Finish Analysis in Single Point Incremental Sheet Forming of Rib-Stiffened 2024-T3 and 7075-T6 Alclad Aluminium Alloy Panels by Tomasz Trzepieciński, Andrzej Kubit, Andrzej Dzierwa, Bogdan Krasowski, Wojciech Jurczak

Get full text

Dynamic Processes Modeling in a Peristaltic Pump with a Hydraulic Drive for the Bingham Fluid by Olha Dvirna, Vladimir Shatokhin, Yaroslav Ivanchuk, Natalia Veselovskaya, Wojciech Jurczak

Get full text

The Rapeseed Oil Based Organofunctional Silane for Stainless Steel Protective Coatings by Karol Szubert, Jarosław Wojciechowski, Łukasz Majchrzycki, Wojciech Jurczak, Grzegorz Lota, Hieronim Maciejewski

Get full text

Microstructural and Fractographic Analysis of Plastically Deformed Al-Zn-Mg Alloy Subjected to Combined High-Cycle Bending-Torsion Fatigue by Aleksander Kowalski, Wojciech Ozgowicz, Wojciech Jurczak, Adam Grajcar, Sonia Boczkal, Andrzej Kurek

Get full text

Analysis of Surface Texture and Roughness in Composites Stiffening Ribs Formed by SPIF Process by Raheem Al-Sabur, Andrzej Kubit, Hassanein I. Khalaf, Wojciech Jurczak, Andrzej Dzierwa, Marcin Korzeniowski

Get full text

P1088: COMPARISON OF BLEEDING-RELATED EVENTS IN PATIENTS WHO RECEIVED PIRTOBRUTINIB WITH AND WITHOUT ANTITHROMBOTIC AGENTS by Nicole Lamanna, Constantine Tam, Wojciech Jurczak, Arrin Kontos, Heiko Konig, Amy S. Ruppert, Donald E. Tsai

Get full text

P1094: SAFETY AND EFFICACY OF ACALABRUTINIB, BENDAMUSTINE, AND RITUXIMAB IN PATIENTS WITH TREATMENT-NAIVE OR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: PHASE IB TRIAL by Tycel Phillips, Michael Wang, Tadeusz Robak, David Gallinson, Don Stevens, Krish Patel, Safaa Ramadan, Chuan-Chaun Wun, Wojciech Jurczak, Stephen D. Smith

Get full text

P1126: PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) by Paolo Strati, Franck Morschhauser, Alexey Danilov, Chan Cheah, Harsh Shah, Wojciech Jurczak, Damilola Olabode, Stefanie Meyer, Jeong Lim Yoon, Serena Arduini, Jamal Saeh, Richardp Olsson, Gareth Gregory

Get full text

Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial by Marco Montillo, Árpád Illés, Tadeusz Robak, Alexander S. Pristupa, Malgorzata Wach, Miklós Egyed, Julio Delgado, Wojciech Jurczak, Franck Morschhauser, Anna Schuh, Herbert Eradat, Sanatan Shreay, Jacqueline C. Barrientos, Andrew D. Zelenetz

Get full text

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation by Brendan P. Hodkinson, Michael Schaffer, Joshua D. Brody, Wojciech Jurczak, Cecilia Carpio, Dina Ben-Yehuda, Irit Avivi, Ann Forslund, Muhit Özcan, John Alvarez, Rob Ceulemans, Nele Fourneau, Anas Younes, Sriram Balasubramanian

Get full text

PB2304: FIVE-YEAR SUBGROUP ANALYSIS OF TAFASITAMAB + LENALIDOMIDE FROM THE PHASE II L-MIND STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA by Johannes Duell, Pau Abrisqueta, Martin Dreyling, Gianluca Gaidano, Eva González Barca, Wojciech Jurczak, Anna Marina Liberati, Kami Maddocks, Tobias Menne, Zsolt Nagy, Olivier Tournilhac, Abhishek Bakuli, Aasim Amin, Konstantin Gurbanov, Gilles Salles

Get full text

P618: LONG-TERM SAFETY WITH ≥12 MONTHS OF PIRTOBRUTINIB IN RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES by Wojciech Jurczak, Catherine C. Coombs, Nirav N. Shah, Jennifer Woyach, Chan Y. Cheah, Krish Patel, Kami Maddocks, Yucai Wang, Catherine E. Muehlenbein, Chunxiao Wang, Sarang Abhyankar, Donald E. Tsai, Toby A. Eyre

Get full text

Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia by Wojciech Jurczak, Nagah Elmusharaf, Christopher P. Fox, William Townsend, Amanda G. Paulovich, Jeffrey R. Whiteaker, Fanny Krantz, Chuan-Chuan Wun, Graeme Parr, Shringi Sharma, Veerendra Munugalavadla, Richa Manwani, Emma Dean, Talha Munir

Get full text

Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study by Michael Wang, Radhakrishnan Ramchandren, Robert Chen, Lionel Karlin, Geoffrey Chong, Wojciech Jurczak, Ka Lung Wu, Mark Bishton, Graham P. Collins, Paul Eliadis, Frédéric Peyrade, Yihua Lee, Karl Eckert, Jutta K. Neuenburg, Constantine S. Tam

Get full text

P1138: FIVE-YEAR EFFICACY AND SAFETY OF TAFASITAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY DLBCL: FINAL RESULTS FROM THE PHASE II L-MIND STUDY by Johannes Duell, Pau Abrisqueta, Marc Andre, Marinela Augustin, Gianluca Gaidano, Eva González Barca, Wojciech Jurczak, Nagesh Kalakonda, Anna Marina Liberati, Kami Maddocks, Tobias Menne, Zsolt Nagy, Olivier Tournilhac, Abhishek Bakuli, Aasim Amin, Konstantin Gurbanov, Gilles Salles

Get full text